MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2024 International Congress

    Association between Morbidity and Social Vulnerability in Patients with Huntington Disease

    J. Patino, N. Rocha, S. Zadegan, B. Duncan, R. Ramphul, A. Sharrief, E. Furr Stimming (Houston, USA)

    Objective: To investigate how social vulnerability affects clinical outcomes in Huntington disease (HD) gene expansion carriers (HDGECs). Background: Social determinants of health (SDOH) are nonmedical…
  • 2024 International Congress

    Movement Disorders in the Emergency:New Insights

    A. Banik, D. Manna, S. Pal, A. Chakravarty, I. Dutta, A. Chattopadhyay, S. Banerjee (kolkata, India)

    Objective: The study objective was to assess the clinico-epidemiological aspects of patients attending the Emergency with movement disorder as the primary symptom. Background: Available literature…
  • 2024 International Congress

    Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease

    G. Olmedo Saura, J. Perez Perez, S. Martinez-Horta, A. Puig-Davi, A. Horta-Barba, A. Vazquez-Oliver, A. Campolongo, E. Rivas-Asensio, N. Salvat-Rovira, D. Alcolea, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate the presence of beta-amyloid pathology in Huntington's disease (HD) and its potential impact on patients' cognitive status. Background: Recent evidence indicates that…
  • 2024 International Congress

    Machine Learning-Driven Exploration of Epigenetic Patterns in Huntington’s Disease: Understanding Histone Modification Dynamics

    R. Fajar, E. Syfaruddin, S. Putri (Sleman, Indonesia)

    Objective: This study explores histone modifications, an underexplored aspect of HD's epigenetics, aiming to uncover markers influencing disease severity and onset for potential therapeutic targets.…
  • 2024 International Congress

    Modifiable factors associated with Huntington’s disease progression in presymptomatic participants: explained longitudinal machine learning modelling

    A. Gil-Salcedo, R. Massart, L. Cleret-de-Langavant, A. Bachoud-Levi (Paris, France)

    Objective: We aimed to identify, as early as the presymptomatic phase, the modifiable factors likely to influence the progression of Huntington's disease (HD), while identifying…
  • 2024 International Congress

    Serum urea and clinical outcomes in Huntington’s disease

    O. Makos, J. Badenoch, M. Hartmann, N. Martin, A. Rangel-Cristales, J. Valera-Bermejo, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To investigate the relationship between serum urea levels and clinical outcomes in people with Huntington’s disease. Background: Several studies in people with Huntington’s disease…
  • 2023 International Congress

    A case of trichotillomania as the preceding symptom of Huntington’ s diseaseand the effect of risperidone

    Y. Degirmenci, N. Bicak (Istanbul, Turkey)

    Objective: Huntington's disease (HD) is a rare neurodegenerative disorder inherited by an autosomal dominant fashion which is most commonly characterised by choreic movement disorders. However,…
  • 2023 International Congress

    Modifying clinical and electrophysiological parameters through Transcranial pulsed current stimulation (tPCS) in Huntington disease

    M. Tuesta Bernaola, J. Ganguly, A. Parra Peña, M. Jog (London, Canada)

    Objective: 1. To assess brain network dysfunction of Huntington disease (HD). 2. To evaluate the effectiveness of 2-week home-based chronic non-invasive transcranial brain stimulation to…
  • 2023 International Congress

    Discriminative properties and sensitivity to change of three cognitive assessment instruments in Huntington’s disease

    A. Horta-Barba, S. Martinez-Horta, J. Pérez-Pérez, A. Puig-Davi, N. de Lucia, G. de Michele, E. Salvatore, S. Kehrer, J. Priller, S. Migliore, F. Squitieri, A. Castaldo, C. Mariotti, V. Mañanes, J. Lopez-Sendon, N. Rodriguez, A. Martinez-Descals, F. Júlio, C. Januário, M. Delussi, M. de Tommaso, S. Noguera, J. Ruiz-Idiago, E. J. Sitek, R. Wallner, A. Nuzzi, J. Pagonabarraga, J. Kulisevsky, HD. Disease Network (BARCELONA, Spain)

    Objective: We addressed and compared the discriminative properties of different cognitive instruments, and we determined the sensitivity to change of the proposed assessments in the…
  • 2023 International Congress

    RNF216–associated neurodegeneration: Is it a new NBIA disorder?

    NS. Sriram (Banglore, India)

    Objective: To describe certain unique clinical and imaging features in a patient with RNF216-associated neuro degeneration (RNF216-AN) Background: RNF216-AN, known as Gordon Holmes syndrome is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley